Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 2
2003 6
2004 1
2005 2
2006 4
2007 1
2008 4
2009 2
2010 2
2011 5
2012 4
2013 3
2014 4
2015 2
2016 4
2017 2
2018 5
2019 5
2020 2
2021 1
2022 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
Enzalutamide versus Abiraterone Plus Prednisolone for Nonmetastatic Castration-Resistant Prostate Cancer: A Sub-Analysis from the ENABLE Study for PCa.
Mita K, Izumi K, Goriki A, Tasaka R, Hatayama T, Shima T, Kato Y, Kamiyama M, Inoue S, Tanaka N, Hoshi S, Okamura T, Yoshio Y, Enokida H, Chikazawa I, Kawai N, Hashimoto K, Fukagai T, Shigehara K, Takahara S, Kadono Y, Mizokami A. Mita K, et al. Among authors: okamura t. Cancers (Basel). 2024 Jan 24;16(3):508. doi: 10.3390/cancers16030508. Cancers (Basel). 2024. PMID: 38339260 Free PMC article.
Enzalutamide Versus Abiraterone plus Prednisolone Before Chemotherapy for Castration-resistant Prostate Cancer: A Multicenter Randomized Controlled Trial.
Izumi K, Shima T, Mita K, Kato Y, Kamiyama M, Inoue S, Tanaka N, Hoshi S, Okamura T, Yoshio Y, Enokida H, Chikazawa I, Kawai N, Hashimoto K, Fukagai T, Shigehara K, Takahara S, Kadono Y, Mizokami A. Izumi K, et al. Among authors: okamura t. Eur Urol Open Sci. 2022 May 19;41:16-23. doi: 10.1016/j.euros.2022.04.016. eCollection 2022 Jul. Eur Urol Open Sci. 2022. PMID: 35813251 Free PMC article.
Skeletal Muscle Mass Reduction Velocity as a Simple Prognostic Indicator for Patients with Metastatic Urothelial Carcinoma Receiving Second-Line Chemotherapy.
Nagai T, Naiki T, Iida K, Nozaki S, Etani T, Sugiyama Y, Ando R, Yanase T, Chaya R, Moritoki Y, Kobayashi D, Akita H, Okamura T, Yasui T. Nagai T, et al. Among authors: okamura t. Asian Pac J Cancer Prev. 2019 Oct 1;20(10):2995-3000. doi: 10.31557/APJCP.2019.20.10.2995. Asian Pac J Cancer Prev. 2019. PMID: 31653146 Free PMC article.
Diagnostic performance of 18F-fluciclovine PET/CT for regional lymph node metastases in patients with primary prostate cancer: a multicenter phase II clinical trial.
Suzuki H, Jinnouchi S, Kaji Y, Kishida T, Kinoshita H, Yamaguchi S, Tobe T, Okamura T, Kawakita M, Furukawa J, Otaka A, Kakehi Y. Suzuki H, et al. Among authors: okamura t. Jpn J Clin Oncol. 2019 Sep 1;49(9):803-811. doi: 10.1093/jjco/hyz072. Jpn J Clin Oncol. 2019. PMID: 31095314 Clinical Trial.
60 results